PlainPharmaWatch

CMS Open Payments · Tool

CooperSurgical, Inc. vs PROCEPT BioRobotics Corporation

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

CooperSurgical, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 3,590, versus 405 for the other company. Its single largest recorded recipient represents 0.6% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

CooperSurgical, Inc.
HHI 3,590 · top recipient 0.6%
Ranked #489 of 1,838 companies by HHI
PROCEPT BioRobotics Corporation
HHI 405 · top recipient 0.1%
Ranked #1,371 of 1,838 companies by HHI

Payment Overview

Total Payments
$1.9M
% of Industry
0.0%
Transactions
9,542
Avg per Transaction
$201.90
Recipients
9,542
Avg per Recipient
$201.90
Payment Types
5
Top Payment Type
Royalty or License
Total Payments
$1.9M
% of Industry
0.0%
Transactions
8,040
Avg per Transaction
$239.61
Recipients
8,013
Avg per Recipient
$240.42
Payment Types
7
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

CooperSurgical, Inc. vs PROCEPT BioRobotics Corporation - total reported payments in CMS Open Payments PY2024

CooperSurgical, Inc.$1.9MPROCEPT BioRobotics Corpora…$1.9M

Payment Types Breakdown

CooperSurgical, Inc.

Royalty or License $1.6M

81.9%

Food and Beverage $225.2K

11.7%

Consulting Fee $114.8K

6.0%

Education $5.3K

0.3%

Travel and Lodging $4.4K

0.2%

PROCEPT BioRobotics Corporation

Consulting Fee $930.8K

48.3%

Food and Beverage $408.9K

21.2%

Travel and Lodging $274.6K

14.3%

Compensation for Services Other Than Consulting $110.1K

5.7%

Long-Term Medical Supply or Device Loan $9.9K

0.5%

Gift $1.2K

0.1%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

CooperSurgical, Inc.

  1. 1

    CHARLES H. KOH

    $1,125,110.72 · 4 txns

  2. 2

    ARNOLD ADVINCULA

    $202,572.00 · 8 txns

  3. 3

    NATHAN ROBERTO FISCHER

    $146,861.46 · 5 txns

  4. 4

    MARK DEUTCHMAN

    $33,637.73 · 11 txns

  5. 5

    MARCO PELOSI

    $25,408.77 · 5 txns

PROCEPT BioRobotics Corporation

  1. 1

    RAVI MUNVER

    $195,767.61 · 144 txns

  2. 2

    LEWIS KRITEMAN

    $182,255.69 · 91 txns

  3. 3

    BRIAN HELFAND

    $128,420.20 · 115 txns

  4. 4

    DAVID CUELLAR

    $114,499.85 · 84 txns

  5. 5

    FREDERIC MOLL

    $81,585.97 · 10 txns

Summary Comparison

Metric CooperSurgical, Inc. PROCEPT BioRobotics Corporation
Total Payments $1.9M $1.9M
% of Industry Total 0.0% 0.0%
Transaction Count 9,542 8,040
Avg per Transaction $201.90 $239.61
Recipient Count 9,542 8,013
Avg per Recipient $201.90 $240.42
Payment Type Count 5 7
Top Payment Type Royalty or License Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.